CEO and co-founder of Injective Labs
Eric Chen, is CEO and co-founder of Injective Protocol.
The desire to build a truly decentralized derivatives exchange led him on a journey from hedge funds to eventually being incubated by Binance, the world’s leading digital assets exchange. During this process, Chen learned valuable lessons about how a pragmatic approach to innovation can help companies gain a competitive advantage and succeed in the fast-paced world of tech. Injective is an open interoperable smart contracts platform optimized for decentralized finance applications. Prior to Injective Protocol, He was a researcher
at Innovating Capital working on trading strategies and protocol Research
. Eric Chen attended New York University where he gained a Bachelor of Science - BS, CS . He also holds a Bachelor's degree in Finance from the New York University Stern School of Business. More Details